The cryo‐EM structure of the Plasmodium falciparum 20S proteasome and its use in the fight against malaria
Open Access
- 11 June 2016
- journal article
- research article
- Published by Wiley in The FEBS Journal
- Vol. 283 (23) , 4238-4243
Abstract
Plasmodium falciparum is the parasite responsible for the most severe form of malaria. Its increasing resistance to existing antimalarials represents a major threat to human health and urges the development of new therapeutic strategies to fight malaria. The proteasome is a protease complex essential in all eukaryotes. Accordingly, inhibition of the Plasmodium 20S proteasome is highly toxic for the parasite at all of its infective and developmental stages. Proteasome inhibitors have antimalarial potential both as curative and transmission blocking agents, but in order to have therapeutic application, they must specifically target the Plasmodium proteasome and not its human counterpart. X‐ray crystallography has been widely used to determine structures of yeast and mammalian 20S proteasomes with ligands. However, crystallisation of the Plasmodium proteasome is challenging, as only small quantities of the complex can be directly purified from the parasite. Furthermore, most X‐ray structures of proteasome–inhibitor complexes require soaking of crystals with high concentrations of ligand, thus preventing analysis of inhibitor subunit specificity. Instead we chose to determine the Plasmodium falciparum 20S proteasome structure, in the presence of a new rationally designed parasite‐specific inhibitor, by high‐resolution electron cryo‐microscopy and single particle analysis. The resulting map, at a resolution of about 3.6 Å, allows a direct molecular analysis of inhibitor/enzyme interactions. Here we present an overview of this structure, and how it provides valuable information that can be used to assist in the design of improved proteasome inhibitors with the potential to be developed as next‐generation antimalarial drugs.Keywords
Funding Information
- Medical Research Council (MC_UP_1201/5)
- National Institutes of Health (R01AI078947, R01EB05011)
- Agency for Science, Technology and Research
This publication has 22 references indexed in Scilit:
- Rational Design of Proteasome Inhibitors as Antimalarial DrugsAngewandte Chemie International Edition, 2016
- Structure- and function-based design of Plasmodium-selective proteasome inhibitorsNature, 2016
- Measuring the optimal exposure for single particle cryo-EM using a 2.6 Å reconstruction of rotavirus VP6eLife, 2015
- Spread of Artemisinin Resistance in Plasmodium falciparum MalariaNew England Journal of Medicine, 2014
- The Resolution RevolutionScience, 2014
- Intracellular protein degradation: From a vague idea through the lysosome and the ubiquitin–proteasome system and onto human diseases and drug targetingBioorganic & Medicinal Chemistry, 2013
- Validation of the Proteasome as a Therapeutic Target in Plasmodium Using an Epoxyketone Inhibitor with Parasite-Specific ToxicityChemistry & Biology, 2012
- Covalent and non-covalent reversible proteasome inhibitionBiological Chemistry, 2012
- 20S Proteasome and Its Inhibitors: Crystallographic Knowledge for Drug DevelopmentChemical Reviews, 2007
- Crystal Structure of the 20 S Proteasome from the Archaeon T. acidophilum at 3.4 Å ResolutionScience, 1995